Download PDF
Exp Clin Endocrinol Diabetes 2024; 132(04): 223-226
DOI: 10.1055/a-2269-1594
Article

Laparoscopic Adrenal Gland Surgery in Times of COVID – Is a Safety-Interval Before Surgery After COVID-Infection Still Mandatory?

Lina Lang   ‡
1   Department of General, Visceral and Transplantation Surgery, LMU Munich, Munich, Germany
,
Malte Schirren   ‡
1   Department of General, Visceral and Transplantation Surgery, LMU Munich, Munich, Germany
,
Ulrich Wirth
1   Department of General, Visceral and Transplantation Surgery, LMU Munich, Munich, Germany
,
Klaus Hofmann-Kiefer
2   Department of Anesthesiology, LMU Munich, Munich, Germany
,
Matthias Kroiss
3   Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany
,
Jens Werner
1   Department of General, Visceral and Transplantation Surgery, LMU Munich, Munich, Germany
,
Petra Zimmermann
1   Department of General, Visceral and Transplantation Surgery, LMU Munich, Munich, Germany
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Due to a multicenter study early in the coronavirus disease (COVID)-pandemic that revealed an increased risk for postoperative mortality, thromboembolic and pulmonary complications in case of surgery shortly after a COVID infection, current recommendations for planning elective surgeries suggest postponing surgery for at least 7 weeks after COVID infection. However, virus variants have evolved throughout the pandemic, leading to less severe symptoms. Besides, laparoscopic adrenal gland surgery itself is a safe procedure with low morbidity rates. Therefore, this study aimed to compare the perioperative course of patients undergoing laparoscopic adrenalectomy shortly after a COVID-19 infection with those who had not had a recent SARS-CoV-2 infection in 2022.

Patients, Material, and Methods All patients who underwent laparoscopic adrenalectomy at the Department for General, Visceral and Transplantation Surgery at Ludwig-Maximilian University between January and December 2022 were included.

Results There was no event of thromboembolic or pulmonary complications in the study population. Duration of surgery did not differ between the two groups; neither did the need for postoperative ICU-admittance nor the duration of ICU-stay. Intraoperative FiO2 did not differ, nor did the SpO2 or the number of different catecholamines. There was a slight trend towards higher noradrenaline dosage among patients after COVID-19 infection. Previous COVID infection did not lead to prolonged hospital stays.

Conclusion The results demonstrate that in case of well-standardized surgical procedures, with a limited surgical trauma and the possibility for patients to be mobilized early, surgery shortly after a mild COVID infection seems safe and reasonable.

Keywords

adrenal gland surgery - SARSCoV-2-infection - perioperative outcome

‡ contributed equally: Lina Lang, Malte Schirren.




Publication History

Received: 17 December 2023
Received: 01 February 2024

Accepted: 06 February 2024

Article published online:
08 March 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 COVIDSURG Collaborative. Timing of surgery following SARS-CoV-2infection: An international prospective cohort study. Anaesthesia 2021; 76: 748-758
    CrossrefPubMedGoogle Scholar
  • 2 COVIDSURG Collaborative. SARS-CoV-2 vaccination modelling for sage surgery to save lives: Data from an international prospective cohort study. Br J Surg 2021; 27: 1056-1063
    CrossrefPubMedGoogle Scholar
  • 3 COVIDSURG Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: An international prospective cohort study. Anaesthesia 2022; 77: 28-39
    CrossrefPubMedGoogle Scholar
  • 4 Gebran A, Gaitanidis A, Argandykov A. et al. Mortality and pulmonary complications in emergency general surgery patients with COVID-19: A large international multicenter study. COVIDSurg Collaborative. J Trauma Acute Care Surg 2022; 93: 59-65
    CrossrefPubMedGoogle Scholar
  • 5 Becke-Jakob K, Geldner G, Vescia F. et al. Aktualisierung der Empfehlungen BDAktuell | DGAInfo. Zeitpunkt elektiver Eingriffe nach SARS-CoV-2-Infektion und Impfung. Deutsches Ärzteblatt 2022; 119: A-964/B-802
    PubMedGoogle Scholar
  • 6 Walz MK. The choice between transperitoneal and retroperitoneal adrenalectomy. Chirurg 1998; 69: 613-620
    PubMedGoogle Scholar
  • 7 Kneist W, Vetter G, Kann P. et al. The choice between transperitoneal and retroperitoneal adrenalectomy. A prospective study. Chirurg 2004; 75: 1098-1103
    PubMedGoogle Scholar
  • 8 Walz MK. Minimally invasive adrenal gland surgery. Transperitoneal or retroperitoneal approach? Chirurg 2012; 83: 536-545
    PubMedGoogle Scholar
  • 9 Alemanno G, Bergamini C, Prosperi P. et al. Adrenalectomy: Indications and options for treatment. Updates Surg 2017; 69: 119-125
    CrossrefPubMedGoogle Scholar
  • 10 Taskin HE, Siperstein A, Mercan S. et al. Laparoscopic posterior retroperitoneal adrenalectomy. J Surg Oncol 2012; 106: 619-621
    CrossrefPubMedGoogle Scholar
  • 11 Deng JZ, Chan JS, Potter Al. et al. The risk of postoperative complications after major elective surgery in active or resolved COVID-19 in the United States. Ann Surg 2022; 275: 242-246
    CrossrefPubMedGoogle Scholar
  • 12 CoVariants. https://covariants.org/. Accessed 14 January, 2022
    PubMed